Advarra is a company dedicated to advancing clinical research, as reflected in the company's slogan: "Advancing clinical research: safer, smarter, faster." Established in 1983, the company focuses on the pharmaceutical industry. Advarra's core objective is to revolutionize the way clinical research is approached by uniting life sciences companies, CROs, research sites, investigators, and academia. This is achieved through a comprehensive approach that centers on safety, technology, and collaboration. Advarra's offerings encompass trusted IRB and IBC review solutions, pioneering technologies, experienced consultants, and extensive industry connections. The company's integrated solutions play a critical role in safeguarding trial participants, empowering clinical sites, ensuring compliance, and optimizing research performance. Advarra is committed to advancing clinical trials to make them safer, smarter, and faster, which reflects the very essence of its slogan. The company's website, advarra.com, provides additional information for those interested in delving deeper into its operations and impact on the field of clinical research. While specific details about the company's headquarters, last investment, and investors are not available, Advarra's overarching mission and focus on advancing clinical research render it an intriguing prospect for potential investors and stakeholders in the pharmaceutical and clinical research spheres.
There is no investment information
No recent news or press coverage available for Advarra.